Market Place
Sourcing Support
Teva’s rating cut to junk; Two Lupin facilities receive FDA warning letters
This week in Phispers, we look at the contrasting 2017 forecasts of Mylan and Teva, resulting from t
China shuts plants of major antibiotic producers to fight pollution; more troubles for Teva
This week, Phispers has lots on generics. While the global leader Teva has more troubles at hand, ge
Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs
With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch
